Life Sciences Summit Speakers
Lisa DYson, PhD
CEO @ Air Protein
CEO & Co-Founder @ Totus Medicines
Ceo @ CH4 Global
SVP and Treasurer- Finance/Proc/GBS/ Strategy @ Lilly
Partner @ DCVC
GP @ Flagship Pioneering
Managing Partner @ DCVC Bio
VP @ Lilly New Ventures
December 9, 2021
1:00pm – 1:10pm ET
1:10pm – 1:35pm ET
Dr. Kiersten Stead of DCVC Bio
This session will map the Life Sciences Technology and Investing landscape. Learn what is cutting edge and hear, first-hand, how a Managing Partner examines investing.
1:35pm – 1:55pm ET
David Berry, GP of Flagship Pioneering
This special session features David Berry, General Partner at Flagship Pioneering, who will share his expertise and insights from creating groundbreaking companies. David has co-founded more than 20 companies across Life Sciences and Sustainability, including Valo, where he serves as CEO. Other companies include Joule, Seres Therapeutics (NASDAQ: MCRB), T2Biosystems (NASDAQ: TTOO), Indigo Agriculture, Evelo Biosciences
1:55pm – 2:30pm ET
Jason Pontin of DCVC
In this session, discover how Venture Firms analyze Life Sciences Startup Companies in various stages of development (Pre-seed, Seed, Series A, Series B), and how Founders should approach company-building, with this in mind.
2:30pm – 3:00pm ET
Dr. Lisa Dyson of Air Protein
What is the state of Startups in the Life Science industry? In this fireside chat, Malcolm Robinson, Founder and Executive Director of BVCC, and Dr. Lisa Dyson, Founder and CEO of Air Protein, will discuss how to identify trends, opportunities, and challenges when building a Life Sciences company.
3:00pm – 3:10pm ET
3:10pm – 3:40pm ET
Philip Johnson & Brad Robling of Lilly – Strategic Perspective
As a Global leader in medicine, the Eli Lilly team has unique insights into life science entrepreneurship. In this session, you’ll learn about Eli Lilly’s strategic engagement with entrepreneurs, startups at all phases of their journey, and as an investor in companies and venture capital funds.
3:40pm – 4:20pm ET
CH4 Global Inc – Steve Meller, CEO
CH4 Global is using sustainable aquaculture to impact climate change at scale. CEO Steve Meller will take you on his journey as a Founder, discussing how CH4 Global developed a leading Life Sciences company. Steve has offered the following Problem Set for your evaluation and discussion – ‘See the CH4 Global Problem Set’
4:20pm – 5:00pm ET
Totus Medicines – Neil Dhawan, CEO
Totus Medicines is making every disease treatable by making the total human genome druggable. Be the first to hear about their breakthrough drug discovery technology, and CEO and Founder Neil Dhawan’s experience bringing Totus to market. Neil has also provided two Problem Sets for your consideration – ‘See Totus Medicines’ ’Problem Sets ’
Happy Hour / Networking
Network with the group, get questions answered, or simply socialize via Gather.Town.